Cyclerion Therapeutics Inc. (CYCN)
NASDAQ · Healthcare
Cyclerion Therapeutics Inc. Income Statement 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 2.1M | 2.0M | 0 | 297,000 | 3.9M | 2.3M | 4.5M |
| Gross Profit | — | — | — | — | — | — | — |
| Profitability | |||||||
| Operating Income | -5.0M | -3.6M | -13.0M | -18.5M | -55.2M | -81.3M | -125.0M |
| EBITDA | — | — | -13.0M | -18.5M | -54.7M | -79.0M | -122.3M |
| Net Income | -3.5M | -3.1M | -5.3M | -44.1M | -51.6M | -77.8M | -123.0M |
| Per Share Data | |||||||
| EPS (diluted) | $-1.11 | $-1.21 | $-2.25 | $-20.28 | $-1.32 | — | — |
| Shares Outstanding (dil.) | 3M | 3M | 2M | 2M | 39M | 34M | 28M |
Cyclerion Therapeutics Inc. Income Statement — FAQ
Cyclerion Therapeutics Inc. (CYCN) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CYCN's income statement history?
The chart and table above show Cyclerion Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.